Creative Financial Designs’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Other funds holding DAWN
Creative Financial Designs's DAWN Position: Q2 2026 in Review
Creative Financial Designs sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 20 shares — an estimated $429 sold.
Creative Financial Designs first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $429 in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- Creative Financial Designs reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Creative Financial Designs sold 20 Day One Biopharmaceuticals shares in Q2 2026, an estimated $429.
- Creative Financial Designs first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
- Creative Financial Designs's Day One Biopharmaceuticals position peaked at $429 in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.